AI assistant
ANGIODYNAMICS INC — Director's Dealing 2017
Jul 28, 2017
32939_dirs_2017-07-28_b4aaa08c-3354-4f52-92ca-f77c03e791af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-07-26
Reporting Person: Clemmer James C (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-26 | Common Stock | A | 22092 | — | Acquired | 113775 | Direct |
| 2017-07-27 | Common Stock | F | 1958 | $16.36 | Disposed | 111817 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-26 | Non-Qualified Stock Option (right to buy) | $16.55 | A | 77627 | Acquired | 2027-07-26 | Common Stock (77627) | Direct |
| 2017-07-26 | Performance Right | $ | A | 44184 | Acquired | Common Stock (44184) | Direct |
Footnotes
F1: This acquisition of 22,092 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 22,092 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021.
F2: The exempt disposition of 1,958 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016.
F3: These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021.
F4: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.